{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:28:32Z","timestamp":1789162112481,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejca.2025.115664","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T16:19:36Z","timestamp":1753805976000},"page":"115664","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 \u2013 A multinational population-based cohort study"],"prefix":"10.1016","volume":"227","author":[{"given":"Anna Norberg","family":"Hardie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4502-2724","authenticated-orcid":false,"given":"Hans H.B.","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine H.","family":"Schnack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maaike A.","family":"Van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pernille T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud L.M.","family":"Bekkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-9421","authenticated-orcid":false,"given":"Henrik","family":"Falconer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ejca.2025.115664_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16142541","article-title":"Management for cervical cancer patients: a comparison of the guidelines from the international scientific societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO)","volume":"16","author":"Restaino","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ejca.2025.115664_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a gynecologic oncology group study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ygyno.2018.10.018","article-title":"Surgical treatment of \"intermediate risk\" lymph node negative cervical cancer patients without adjuvant radiotherapy-a retrospective cohort study and review of the literature","volume":"151","author":"Cibula","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2025.115664_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2023.01.014","article-title":"Role of adjuvant therapy in intermediate-risk cervical cancer patients - subanalyses of the SCCAN study","volume":"170","author":"Cibula","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ijrobp.2013.06.2059","article-title":"Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study","volume":"87","author":"Gandhi","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"33","key":"10.1016\/j.ejca.2025.115664_bib6","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ijgo.13147","article-title":"Comparison of no adjuvant treatment and radiotherapy in early-stage cervical carcinoma with intermediate risk factors","volume":"149","author":"Akilli","year":"2020","journal-title":"Int J Gynaecol Obstet"},{"issue":"9","key":"10.1016\/j.ejca.2025.115664_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1136\/ijgc-2024-005597","article-title":"Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer","volume":"34","author":"Matsuo","year":"2024","journal-title":"Int J Gynecol Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2025.115664_bib9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s12094-022-02808-9","article-title":"Adjuvant therapy in early-stage cervical cancer after radical hysterectomy: are we overtreating our patients? A meta-analysis","volume":"24","author":"G\u00f3mez-Hidalgo","year":"2022","journal-title":"Clin Transl Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2025.115664_bib10","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines\u00ae Insights: Cervical Cancer, Version 1.2024","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"10.1016\/j.ejca.2025.115664_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/ijgc-2023-004429","article-title":"ESGO\/ESTRO\/ESP Guidelines for the management of patients with cervical cancer - Update 2023","volume":"33","author":"Cibula","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.115664_bib12","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/JGO.2016.003954","article-title":"Management and care of women with invasive cervical cancer: American Society of Clinical Oncology resource-stratified clinical practice guideline","volume":"2","author":"Chuang","year":"2016","journal-title":"J Glob Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2025.115664_bib13","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/ijgc-2021-002489","article-title":"Role of adjuvant radiation therapy after radical hysterectomy in patients with stage IB cervical carcinoma and intermediate risk factors","volume":"31","author":"Nasioudis","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2025.115664_bib14","unstructured":"<2023 SKABELON DMCG rsberetning.pdf>."},{"key":"10.1016\/j.ejca.2025.115664_bib15","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/CLEP.S99479","article-title":"Danish gynecological cancer database","volume":"8","author":"S\u00f8rensen","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib16","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/0284186X.2017.1366048","article-title":"Data quality in the Swedish Quality Register of Gynecologic Cancer - a Swedish Gynecologic Cancer Group (SweGCG) study","volume":"57","author":"Rosenberg","year":"2018","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.ejca.2025.115664_bib17","first-page":"1822","article-title":"Cancer incidence in The Netherlands in 1989 and 1990: first results of the nationwide Netherlands cancer registry","volume":"31a","author":"van der Sanden","year":"1995","journal-title":"Coord Comm Reg Cancer Regist Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2025.115664_bib18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"1","key":"10.1016\/j.ejca.2025.115664_bib19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijrobp.2005.10.019","article-title":"A phase III randomized trial of postoperative pelvic irradiation in Stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study","volume":"65","author":"Rotman","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ejca.2025.115664_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1006\/gyno.1997.4691","article-title":"Stage IB and IIA cervical cancer with negative lymph nodes: the role of adjuvant radiotherapy after radical hysterectomy","volume":"66","author":"Schorge","year":"1997","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2025.115664_bib21","article-title":"Radiotherapy and chemoradiation after surgery for early cervical cancer","volume":"2012","author":"Rogers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/ijgc-00009577-200605000-00026","article-title":"Postoperative radiation therapy improves prognosis in patients with adverse risk factors in localized, early-stage cervical cancer: a retrospective comparative study","volume":"16","author":"Pieterse","year":"2006","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2025.115664_bib23","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"Jama"},{"issue":"9128","key":"10.1016\/j.ejca.2025.115664_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejca.2025.115664_bib25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ygyno.2021.06.017","article-title":"Beyond Sedlis-A novel histology-specific nomogram for predicting cervical cancer recurrence risk: an NRG\/GOG ancillary analysis","volume":"162","author":"Levinson","year":"2021","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2025.115664_bib26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/IGC.0000000000001216","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer","volume":"28","author":"Cibula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2025.115664_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.6004\/jnccn.2015.0055","article-title":"Cervical Cancer, Version 2.2015","volume":"13","author":"Koh","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2025.115664_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102696","article-title":"Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study","volume":"73","author":"Falconer","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.ejca.2025.115664_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2019-000445","article-title":"Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy","author":"van der Velden","year":"2019","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2025.115664_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/ijgc-2022-003918","article-title":"CERVANTES: an international randomized trial of radical surgery followed by adjuvant (chemo) radiation versus no further treatment in patients with early-stage, intermediate-risk cervical cancer (CEEGOG-CX-05; ENGOT-CX16)","author":"Cibula","year":"2022","journal-title":"Int J Gynecol Cancer"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925004460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804925004460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:50:09Z","timestamp":1772877009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804925004460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":30,"alternative-id":["S0959804925004460"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115664","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncological outcomes after radical hysterectomy followed by adjuvant (chemo)radiation or no further treatment in women with cervical cancer FIGO 2018 IB2-IIA2 \u2013 A multinational population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2025.115664","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"115664"}}